About XACT Robotics
XACT Robotics is a privately held healthcare AI company focused on advancing the field of radiology with its hands-free robotic solutions for percutaneous procedures. The company’s flagship product, the XACT ACE® Robotic System, is designed to significantly improve targeting accuracy, efficiency, and consistency in these procedures. It integrates image-guided planning and real-time monitoring with precise robotic insertion and proprietary S-Drive™ technology, which enables non-linear steering to adapt to target movement or obstacles. This allows for accurate and consistent delivery of various instruments, such as those used in biopsies, ablations, drainages, and targeted drug delivery, even for small or difficult-to-reach lesions.
For physicians, the XACT ACE Robotic System offers several key benefits. It aims to remove manual inconsistencies in instrument insertion, potentially reducing procedure complexities and duration. The system’s ability to achieve high accuracy (an average of 1.7mm tip-to-target accuracy upon first insertion in clinical studies) and its capacity for real-time adjustments to instrument trajectory can enhance diagnostic yield and optimize therapeutic interventions. Furthermore, the system is instrument-agnostic, meaning it can be used with existing instruments in a facility, and its small footprint allows for quick integration into clinical workflows without requiring specialized operating space. The XACT ACE Xtend™ Remote Control Unit also allows for robotic insertion and steering remotely from the control room, potentially reducing physician exposure to radiation and physical strain.
Focus Areas
Business Intelligence
| Technology | The XACT ACE® Robotic System utilizes a five-degrees-of-freedom robot, continuous needle path calculation, and real-time closed-loop control with proprietary S-Drive™ technology. It integrates image-guided planning software, real-time imaging checkpoint monitoring (CT), patient-mounted robotic registration and motion compensation, and remote robotic control. The system is instrument-agnostic and designed for compatibility with multiple imaging modalities. |
What Physicians Need to Know
For physicians, the XACT ACEu00ae Robotic System offers significant advantages by improving targeting accuracy, consistency, and efficiency in percutaneous procedures. It enables access to small or difficult-to-reach targets, even with patient or anatomical movement, potentially leading to earlier diagnosis and treatment. The 'hands-free' operation and remote control capabilities can reduce physical strain and radiation exposure for staff, while also allowing for more predictable procedure times and improved workflow efficiency. Its instrument-agnostic nature means it can be quickly integrated into existing facility workflows without requiring new specialized instruments.
The XACT ACEu00ae Robotic System integrates with existing imaging modalities such as CT and ultrasound. It is designed to be instrument-agnostic, meaning it can utilize various instruments already stocked within a facility for different procedures. The system also features a small footprint and mobility, allowing for efficient setup and transportation across multiple procedure rooms.
What the Web Says
XACT Robotics developed the XACT ACE Robotic System, a hands-free robotic solution for CT-guided percutaneous procedures, aiming to improve accuracy, efficiency, and consistency in interventional radiology. The system is designed to minimize the need for frequent instrument reinsertion, reduce physical strain and radiation exposure for staff, and allow for more predictable procedure times. While the technology received FDA approval and positive feedback from early adopters regarding its accuracy and ability to compensate for patient movement, the company unfortunately shut down in September 2023 due to a failure to generate significant revenue and secure an acquisition.
Overall: NegativeStrengths
- Improved targeting accuracy (1.7mm average tip to target accuracy)
- Reduced need for frequent instrument reinsertion
- Minimized physical strain and radiation exposure for medical staff
- More predictable and consistent procedure times (< 8.5 minutes average skin to target time)
- Small footprint and high mobility allows for efficient setup and use across multiple procedure rooms
- Potential to allow other health professionals (physician assistants, nurse practitioners) to perform procedures regardless of experience level
Limitations
- Company shut down in September 2023 due to financial difficulties
- Failed to generate significant revenue despite FDA approval and sales starting in 2020
- Employees were largely unaware of the company's troubled state
- Unclear whether employees received full compensation
- Some feedback on usability and design in early generations of the system
- One source suggests a high acquisition offer was turned down in 2020, leading to the company's eventual closure
Based on reviews from: AI-Tech Park, CIO Bulletin, Indeed.com, Globes English, MD+DI, PMC, Reddit
Last updated: 2026-09-03
Videos
News, demos, and interviews about XACT Robotics.
Videos load interactively. If none appear, search YouTube for XACT Robotics →
Press & Coverage
Frequently Asked Questions
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]
CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]